BioSpace News Archive

Hansa Biopharma to Present at the Cowen 39th Annual Health Care Conference

Hansa Biopharma AB announced today that Søren Tulstrup, President and CEO of Hansa Biopharma, will present at the Cowen 39th Annual Health Care Conference on Wednesday, March 13, 2019 at 9:20AM ET/ 3:20PM CET.

March 6, 2019
·
1 min read
Policy

Discover the Next Global Healthcare Era with ‘Medical Korea 2019'

Discussion on trends and changes of global healthcare Industry and strategies for new-tech based medical services

March 6, 2019
·
2 min read
Policy

Brain & Behavior Research Foundation Comments on FDA Approval of New Depression Treatment

The Brain & Behavior Research Foundation (BBRF) applauds the FDA for its approval of Esketamine nasal spray as a new medication for treatment of resistant depression.

March 6, 2019
·
2 min read
Drug Development

Alnylam Reports Positive Topline Results from ENVISION Phase 3 Study of Givosiran in Acute Hepatic Porphyria

Givosiran Meets Primary and Majority of Secondary Endpoints, with Significant Reduction in Annualized Rate of Composite Porphyria Attacks Relative to Placebo

March 6, 2019
·
14 min read
Deals

Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2018 on March 13, 2019

Conference Call Scheduled for Wednesday, March 13 at 4:30 p.m. Eastern Time

March 6, 2019
·
2 min read
BioCapital

HemoShear Therapeutics Physiological Human Tumor Model Published in Lab on a Chip Journal

Model replicates behavior of the pancreatic tumor environment to better understand the disease and assess potential treatments

March 6, 2019
·
3 min read
Business

Lipocine Announces Financial and Operational Results for the Year Ended December 31, 2018

Lipocine Inc., a specialty pharmaceutical company, announced financial results for the year ended December 31, 2018.

March 6, 2019
·
8 min read
Pharm Country

BioIVT Launches Its XPRESSWAY® Profile Safety Package, a Gene Expression Reference Guide Designed to Improve Drug Safety Analyses

This new product will help pharmaceutical companies to assess drug safety risks, inform go/no-go decisions in lead selection, and expedite drug discovery programs

March 6, 2019
·
4 min read
Job Trends

Pharm-Olam Celebrates 25-Year Anniversary and Announces Enhanced Rare Disease Services

Pharm-Olam is marking its 25th anniversary with several announcements.

March 6, 2019
·
3 min read
FDA

Instrumentation Laboratory Receives US FDA Clearance For New Gem Premier Chemstat™ Testing System

- -Designed for Rapid Basic Metabolic Testing in Emergency Departments and Other Hospital Point-of-Care Settings- -

March 6, 2019
·
5 min read